Search

everythinglearnresearchcommunity

for

Search:↓

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

Certain natural compounds called terpenes may help prevent prostate cancer.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The new method found new shared genetic areas linked to both Type 2 Diabetes and Prostate Cancer.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Early baldness in men may indicate a higher risk of prostate cancer.

Early-onset male baldness may indicate a higher risk of prostate cancer.